Cargando…
The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors
Research on adult cancer immunotherapy is proceeding at a rapid pace resulting in an impressive success rate exemplified by a few high profile cases. However, this momentum is not readily extended to pediatric immunotherapy, and it is not for lack of trying. Though reasons for the slower advance are...
Autores principales: | Le, Thanh-Phuong, Thai, To-Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705544/ https://www.ncbi.nlm.nih.gov/pubmed/29225605 http://dx.doi.org/10.3389/fimmu.2017.01640 |
Ejemplares similares
-
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Sloas, Christopher, et al.
Publicado: (2021) -
Non-cellular immunotherapies in pediatric central nervous system tumors
por: Rumler, Sarah
Publicado: (2023) -
Tumor Secretome to Adoptive Cellular Immunotherapy: Reduce Me Before I Make You My Partner
por: Etxebeste-Mitxeltorena, Mikel, et al.
Publicado: (2021) -
Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions
por: Ligon, John A., et al.
Publicado: (2022) -
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
por: Liu, Qiaofei, et al.
Publicado: (2023)